WUXI BIO (02269): Miao Jingwen appointed as non-executive director.
Wu Yibing, Ph.D., has resigned as of November 20, 2024, in an announcement from WuXi Biologics (02269).
WUXI BIO (02269) announces that, effective from November 20, 2024, Dr. Wu Yibing has resigned as a non-executive director and member of the Board's decision-making committee to dedicate more time to other personal matters. Ms. Miao Jingwen has been appointed as a non-executive director and member of the decision-making committee.
Related Articles
Change in controlling ownership: ETS GROUP (08031) receives a cash takeover offer at a discount of approximately 15.08%, and will resume trading on January 20th.
MODERN CHI MED (01643) plans to acquire a 30% stake in Shuzhi Health Global for 41.82 million Hong Kong dollars.
CMON is planning to offer a discount of approximately 16.67% in the maximum of 10.32 million shares, netting approximately 7.9 million Hong Kong dollars.
Change in controlling ownership: ETS GROUP (08031) receives a cash takeover offer at a discount of approximately 15.08%, and will resume trading on January 20th.
MODERN CHI MED (01643) plans to acquire a 30% stake in Shuzhi Health Global for 41.82 million Hong Kong dollars.
CMON is planning to offer a discount of approximately 16.67% in the maximum of 10.32 million shares, netting approximately 7.9 million Hong Kong dollars.
